Moneycontrol
    Moneycontrol PRO
    LAMF
    LAMF

    Warning Letter

    Jump to

    • Indoco Remedies shares fall after USFDA warning letter over Goa facility

      Indoco Remedies said it is in touch with the regulator regarding matter. "We will work with the USFDA to resolve these issues at the earliest," Indoco added.

    • Sebi sent 377 warnings to AIFs in FY24 against 20 in the previous year

      Warnings pertain to disclosure lapses with private placement documents and not swiftly addressing investor grievances among others.

    • USFDA issues warning letter to Kilitch Healthcare for Navi-Mumbai plant

      "Because your drug products were prepared, packed, or held under insanitary conditions, whereby they may have become contaminated with filth or rendered injurious to health," it stated.

    • Committed to maintain highest quality, FDA warning letter on Bardez plant won’t impact supplies: Glenmark

    • Lupin: Somerset warning implies regulatory environment may no longer offer relief

    • Divis Vizag unit fails USFDA audit on alleged reluctance to share drug testing data

    • US FDA asks Indoco Remedies to hire consultant, review manufacturing ops

    • Dr Reddy's gains over 4% on buzz Srikakulam API plant cleared US FDA audit

    • Impact of FDA warning letter on sales minimal, to reply in 15 days: Indoco Remedies

    • Indoco Remedies at 1-year low on USFDA warning letter for Goa facility

    • Indoco Remedies gets USFDA warning letter for its Goa facility

    • Repeat observations on Vizag site spell bad news for Dr.Reddy's

    • USFDA asks Wockhardt to assess quality systems across its plants

    • Dr Reddy's gears up for key USFDA audits in next 2 months: Srcs

    • 5 important things about USFDA warning letters, slow resolution

    • Wockhardt tanks 7% on FDA‘s warning letter to US arm

    • Sensex, Nifty could see a strong start; Wockhardt in focus

    • Analysts give a thumbs-up to Cadila on resolution of FDA warning

    • Cadila gains on resolution of its Moraiya plant warning letter

    • USFDA to re-audit three Dr Reddy's plants

    • German regulator clears Wockhardt's Ankleshwar plant

    • Addressing concern raised by USFDA on Ankleshwar unit: Wockhardt

    • Sun Pharma up 3%; details of warning letter not worrisome

    • Sun Pharma gets warning letter from USFDA over Halol unit

    • Dr Reddy's Labs: The bull vs bear case

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347